Application 208927
- Type
- ANDA
- Sponsor
- BIOCON LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PEMETREXED | PEMETREXED | INJECTABLE;INJECTION | 100MG | No | No |
| 002 | PEMETREXED | PEMETREXED | INJECTABLE;INJECTION | 500MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pemetrexed | PEMETREXED DISODIUM | BluePoint Laboratories | 14974d4e-2f01-4e02-aea2-c28b3ca0781c | 2023-04-26 | Warnings, Adverse reactions | Pemetrexed |
| Pemetrexed | PEMETREXED DISODIUM | Meitheal Pharmaceuticals Inc. | b185f459-5489-4e18-8521-1686b5d16f67 | 2022-12-21 | Warnings, Adverse reactions | Pemetrexed |
| Pemetrexed | PEMETREXED DISODIUM | BluePoint Laboratories | c9f34c00-1176-4f44-8cff-bae5bdc0c40f | 2022-12-08 | Warnings, Adverse reactions | Pemetrexed |
| Pemetrexed | PEMETREXED | Teva Pharmaceuticals, Inc. | 8b660f68-b770-4e0a-b2f9-25e663deecc3 | 2022-12-01 | Warnings, Adverse reactions | Pemetrexed PEMETREXED |
| pemetrexed | PEMETREXED DISODIUM | Zydus Pharmaceuticals USA Inc. | 363665ca-db15-4123-84ac-0ae66b5f1363 | 2022-05-26 | Warnings, Adverse reactions | pemetrexed |
| pemetrexed | PEMETREXED DISODIUM | Zydus Lifesciences Limited | 6986de29-b077-48ac-ad2b-0cc478f72d89 | 2022-05-26 | pemetrexed | |
| Pemetrexed | PEMETREXED DISODIUM | Qilu Pharmaceutical Co., Ltd. | 46a9b89d-7135-4e0c-b8e4-52580554769b | 2021-08-13 | Warnings, Adverse reactions | Pemetrexed |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.